Novo Nordisk Past Performance
How has Novo Nordisk performed over the past 5 years?
Past Performance Score
5/6Past Performance Score 5/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
7.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NOVO B has high quality earnings.
Growing Profit Margin: NOVO B's current net profit margins (31.4%) are lower than last year (33.9%).
Past Earnings Growth Analysis
Earnings Trend: NOVO B's earnings have grown by 7.4% per year over the past 5 years.
Accelerating Growth: NOVO B's earnings growth over the past year (16.3%) exceeds its 5-year average (7.4% per year).
Earnings vs Industry: NOVO B earnings growth over the past year (16.3%) exceeded the Pharmaceuticals industry 15.8%.
Return on Equity
High ROE: NOVO B's Return on Equity (66.5%) is considered outstanding.